Document resource
Chronic obstructive pulmonary disease (COPD) remains a major global health challenge and is characterised by persistent respiratory symptoms and progressive airflow obstruction. 1 It has been traditionally managed as a neutrophilic disease; however, it is now established that about 40% of patients exhibit type 2 inflammation involving elevated blood eosinophil counts.2 3